UVXY News Alert Ultra VIX Short-Term Fut ETF Proshares (UVXY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra VIX Short-Term Fut ETF Proshares (UVXY) 24.33 $UVXY

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 26, 4:35PM CST

TVIX: 2.66 (-0.10), IHT: 2.26 (-0.24), BLCM: 22.86 (-0.18), VXX: 30.99 (-0.52), JNUG: 27.24 (+2.90), UVXY: 24.33 (-0.82), RLGY: 44.19 (-0.30), JD: 24.02 (+0.88), JDST: 13.72 (-1.98), SVXY: 62.27 (+1.11)

The Most Consistent Risk/Reward Speculation That I Have Ever Found
Scott Brown - Seeking Alpha - Fri Dec 19, 1:54PM CST
Everyone loves a good speculation. The problem is that every good speculation has a good bit of risk associated with it, thus the reason why it is considered speculation and not an investment. I've heard all sorts of market "experts" that...
EDZ: 38.84 (+1.33), TZA: 12.19 (+0.19), JNUG: 27.24 (+2.90), UVXY: 24.33 (-0.82), TNA: 79.57 (-1.36), DUST: 22.56 (-2.10), EDC: 22.10 (-0.84), NUGT: 12.10 (+0.94), SVXY: 62.27 (+1.11), JDST: 13.72 (-1.98)

Current Events Provide A VIX Opportunity
Nathan Buehler - Seeking Alpha - Mon Dec 15, 10:35AM CST
Hello everyone! I am happy to be back writing. During the school year, I get very bogged down from August to November. Luckily, academics are going well and things have begun to taper off towards Christmas. Next semester, I am teaching day and night...
UVXY: 24.33 (-0.82), SVXY: 62.27 (+1.11)

The Volatility Battleground
Markit - Seeking Alpha - Mon Dec 15, 6:26AM CST
Volatility has declined since the spike in October, but developments in Greece and oil price effects have disturbed the calm conditions. Volatility was the name of the game earlier in the first quarter as credit was swept up in the maelstrom...
TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), GREK: 13.74 (+0.34), UVXY: 24.33 (-0.82), ACWV: 68.66 (-0.18), VIIX: 41.81 (-0.89), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

The Best Offense Is A Good Defense: Profiting From Hedging
AllAboutAlpha - Seeking Alpha - Thu Dec 04, 4:25PM CST
This time of year one often encounters certain football-fans' truisms. Sometimes one is told "the best defense is a good offense." At other times, "the best offense is a good defense." At yet other times, "it's all in the...
TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), UVXY: 24.33 (-0.82), VIIX: 41.81 (-0.89), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

Doing The Unthinkable: Going Long Volatility
Josh Arnold - at Seeking Alpha - Thu Dec 04, 2:47AM CST

TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), UVXY: 24.33 (-0.82), XIV: 31.69 (+0.55)

The Curious Case Of Elevated Volatility (Weight Of Evidence, Part 2 Of 7)
360 Investment Research - at Seeking Alpha - Tue Nov 18, 2:33PM CST
"Fear tends to manifest itself much quicker than greed, so volatile markets tend to be on the downside. In up markets, volatility tends to gradually decline." ~ Philip Roth The CBOE Volatility Index is often referred to as the FEAR Index....
TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), UVXY: 24.33 (-0.82), VIIX: 41.81 (-0.89), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

Contrarian Eats Crow Over Decay Of Two Hedges That Protect Against Coming Dollar And Market Corrections
Bart Gruzalski - at Seeking Alpha - Fri Nov 14, 9:30AM CST

TVIX: 2.66 (-0.10), UVXY: 24.33 (-0.82)

Contrarian Delight: Maybe Last Chance To Invest Or Hedge With UVXY At All Time Lows
Bart Gruzalski - at Seeking Alpha - Fri Nov 07, 4:36PM CST

UVXY: 24.33 (-0.82)

Overcrowded Trade Du Jour: Short Volatility
Jesse Felder - Seeking Alpha - Tue Nov 04, 2:50PM CST
Periods of low volatility are to investors what a sweet lullaby sung by whispering nanny is to an overtired baby. It relaxes them, gets them to put their worries aside and believe that everything is going to be okay. Great for babies. Not so great...
TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), UVXY: 24.33 (-0.82), VIIX: 41.81 (-0.89), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

The VIX And Seasonality: Long Live Santa Claus And The Turkey Gods
Force Majeure - Seeking Alpha - Mon Nov 03, 11:35AM CST
The month of October has certainly been a wild one for U.S. markets with the second half of the month the polar opposite of the first. The first two weeks were dominated by fear regarding global growth, ebola, and geopolitical instability and...
TVIZ: 21.69 (-0.22), TVIX: 2.66 (-0.10), SPY: 205.43 (-0.11), QQQ: 102.94 (-0.31), VXX: 30.99 (-0.52), UVXY: 24.33 (-0.82), VXZ: 13.03 (-0.09), XIV: 31.69 (+0.55)

Is The Latest VIX Decline A Trick Or Treat?
James Picerno - at Seeking Alpha - Thu Oct 30, 1:26PM CDT
It's nearly Halloween, but the frightening rise in U.S. stock market volatility earlier this month is looking less creepy at the moment. In particular, the Volatility Index (VIX) for the S&P 500 has tumbled substantially over the past week,...
TVIX: 2.66 (-0.10), ZIV: 41.99 (+0.22), VXX: 30.99 (-0.52), UVXY: 24.33 (-0.82), VXZ: 13.03 (-0.09), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

Climbing The Latest Wall Of Worry
Calafia Beach Pundit - Seeking Alpha - Tue Oct 28, 4:59PM CDT
As I mentioned about three weeks ago, stocks have been climbing walls of worry throughout the recovery which began some 5 ½ years ago. Almost every selloff in the past two years has been accompanied by/caused by an emotional response to new...
TVIX: 2.66 (-0.10), SPY: 205.43 (-0.11), QQQ: 102.94 (-0.31), VXX: 30.99 (-0.52), DIA: 177.94 (+0.06), UVXY: 24.33 (-0.82), XIV: 31.69 (+0.55)

Volatility Trade Back In Oct 22, 2014 - ETF Gainers And Losers
CapitalCube - Seeking Alpha - Thu Oct 23, 2:04PM CDT
By Veibha Subramaniam The risk-on trade seems to be back again. Buying volatility is back. Yesterday the market was buying the VIX and today as of 10:00 am the VIX ETFs are still gaining - VIXY (+7.84%), VXX (+7.67%), VIXM (+3.16%) The data was...
EGPT: 58.63 (+0.33), JO: 29.09 (-1.39), TZA: 12.19 (+0.19), VXX: 30.99 (-0.52), XOP: 48.35 (+0.49), GREK: 13.74 (+0.34), TNA: 79.57 (-1.36), UVXY: 24.33 (-0.82), HDGE: 11.48 (+0.05), PXI: 45.10 (+0.29), SRTY: 31.33 (+0.43), WIL: 52.96 (-0.13), VXZ: 13.03 (-0.09), XIV: 31.69 (+0.55), ERY: 20.72 (-0.28), GLDX: 10.52 (+0.27), ERX: 61.35 (+0.88), GDXJ: 24.96 (+1.03), JNUG: 27.24 (+2.90), FCG: 11.24 (+0.03), SGDM: 17.98 (+0.42), DUST: 22.56 (-2.10), ZSL: 117.79 (-1.60), JDST: 13.72 (-1.98), URTY: 92.21 (-1.57), SOXS: 13.42 (+0.03), TVIX: 2.66 (-0.10), UCO: 9.91 (-0.46), VIXM: 63.37 (-0.52), SIL: 9.38 (+0.12), NUGT: 12.10 (+0.94), SCO: 79.90 (+3.38), SVXY: 62.27 (+1.11), IPFF: 22.26 (-0.25), USLV: 19.28 (+0.29), RUSL: 17.00 (+0.46), SIZE: 65.32 (-0.21), VIXY: 20.61 (-0.38), PSCE: 29.91 (+0.23), FLGE: 113.15 (-0.68)

Not All Market Hedges Are Created Equal: Part 1
Invesco US - Seeking Alpha - Wed Oct 22, 3:20PM CDT
By John Feyerer While the multi-year bull market may feel like it has created some distance from the market turmoil, investors won't soon forget the global financial crisis of 2008-2009 and the eurozone debt crisis events of 2010-2011. These...
TVIZ: 21.69 (-0.22), TVIX: 2.66 (-0.10), XVZ: 28.60 (+0.12), VIXM: 63.37 (-0.52), XVIX: 16.08 (+0.03), ZIV: 41.99 (+0.22), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), UVXY: 24.33 (-0.82), VIIX: 41.81 (-0.89), CVOL: 1.07 (-0.02), VXZ: 13.03 (-0.09), VIIZ: 18.07 (-0.17), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

How To Hedge Using Volatility ETFs
Investing Crunch - Seeking Alpha - Wed Oct 22, 12:39PM CDT
By Carl Densem Only being able to buy and sell stocks can leave few options when markets head south as they have lately. One can either treat it as a buying opportunity, sell for fear of worse to come or wait it out. And though we like to trust...
TVIX: 2.66 (-0.10), VXX: 30.99 (-0.52), IVOP: 38.04 (-0.07), UVXY: 24.33 (-0.82), VIIX: 41.81 (-0.89), PSQ: 59.63 (+0.15), XXV: 38.31 (unch), VIXY: 20.61 (-0.38), SVXY: 62.27 (+1.11), XIV: 31.69 (+0.55)

Top 10 ETF Gainers And Losers For October 17, 2014
CapitalCube - Seeking Alpha - Sun Oct 19, 8:29AM CDT
By Veibha Subramaniam Top 10 ETF gainers with assets of more than $25 million as of Oct 17, 2014. (Non-Leveraged) The data was compiled using CapitalCube's ETF Screener Symbol Company 1 Day Price Return (%) Average Daily Volume...
JO: 29.09 (-1.39), VXX: 30.99 (-0.52), GREK: 13.74 (+0.34), XOP: 48.35 (+0.49), UVXY: 24.33 (-0.82), FIEU: 106.46 (+2.76), VXZ: 13.03 (-0.09), SDOW: 20.57 (+0.01), XIV: 31.69 (+0.55), SPXU: 38.09 (+0.05), EPV: 64.03 (+0.57), IDX: 23.87 (-0.42), SPXS: 20.67 (+0.07), GLDX: 10.52 (+0.27), SQQQ: 30.03 (+0.19), JNUG: 27.24 (+2.90), SGDM: 17.98 (+0.42), DZK: 56.64 (-0.53), GXF: 22.02 (-0.03), DUST: 22.56 (-2.10), GDX: 18.94 (+0.56), CURE: 125.75 (+1.38), JDST: 13.72 (-1.98), TVIX: 2.66 (-0.10), VIXM: 63.37 (-0.52), CFGE: 10.49 (-0.13), FEEU: 102.85 (-1.04), UXI: 114.97 (-2.82), SIL: 9.38 (+0.12), NUGT: 12.10 (+0.94), SVXY: 62.27 (+1.11), HEWG: 23.61 (+0.08), BXUC: 299.86 (unch), RUSL: 17.00 (+0.46), BRF: 20.44 (-0.63), EIDO: 26.78 (-0.66), EWZ: 35.36 (-1.21), UDOW: 141.33 (-0.13), VIXY: 20.61 (-0.38), ENOR: 23.12 (-0.18)

Another QE Would Be A Disaster
Orange Peel Investments - at Seeking Alpha - Fri Oct 17, 5:09PM CDT

SPY: 205.43 (-0.11), UVXY: 24.33 (-0.82), DIA: 177.94 (+0.06)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading